Pylarify f-18 dcfpyl
Ended Awarded Last action
- Contract number
- 36C25524F0079
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $992,398
Award facts
- Contract value 100% obligated
- $992,398.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- St. Louis, MO 63106, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$180,436 | |
| Original award | $1,172,834 |
About this award
Sofie CO., doing business as IBA Molecular, was awarded a $992,398 delivery order by Veterans Integrated Service Network (VISN) 15, a component of the Department of Veterans Affairs, on June 1, 2024. The award is designated as a total small business set-aside and calls for the supply of PYLARIFY (piflufolastat F-18), a positron emission tomography (PET) imaging agent used for prostate cancer detection. Performance will be completed at the VA Saint Louis Health Care System in St. Louis, Missouri, with a firm fixed-price structure and an ultimate completion date of May 31, 2025. This delivery order is issued under Sofie CO.'s larger indefinite delivery vehicle with VA VISN 15, which provides a comprehensive supply arrangement for PYLARIFY F-18 DCFPYL radiopharmaceuticals supporting advanced diagnostic imaging capabilities across the VA healthcare system.
Sofie CO. is a specialized supplier of molecular diagnostics and therapeutic radiopharmaceuticals with extensive experience serving federal healthcare agencies, including the VA, Defense Health Agency, and National Institutes of Health. The company maintains regulatory compliance with the Nuclear Regulatory Commission and Food and Drug Administration requirements essential for the manufacturing and distribution of radioactive pharmaceuticals. This award reflects the company's established competitive position as a critical vendor of PET imaging agents, enabling VA medical centers to deliver precision diagnostic services for cancer detection and treatment planning to the veteran population served by VISN 15.
Quick answers
Who was awarded contract 36C25524F0079?
36C25524F0079 was awarded to Sofie CO. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2024.
How much is contract 36C25524F0079 worth?
The government has obligated $992,398 on 36C25524F0079.
Is contract 36C25524F0079 an order under another contract?
Yes. 36C25524F0079 is a delivery order under 36C25524D0411, an indefinite delivery contract.
Was contract 36C25524F0079 competed?
The extent of competition for 36C25524F0079 was competed under sap. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award